A multiplex PCR assay for detection of the staphylococcal mecA gene (the structural gene for penicillinbinding protein 2a) was compared with agar dilution and disk diffusion susceptibility test methods for identifying methicillin resistance. The multiplex PCR assay combined two primer sets (mecA and 16S rRNA) in a single reaction. A total of 500 staphylococcal isolates (228 isolates of Staphylococcus aureus and 272 isolates of coagulase-negative staphylococci) from clinical specimens were studied. For S. aureus, 40 of 40 mecA-positive isolates and 4 of 188 mecA-negative isolates were oxacillin resistant (positive and negative predictive values of 100 and 98%, respectively). In 3 of 4 discordant isolates, resistance was due to hyperproduction of ,-lactamase. For coagulase-negative staphylococci, 148 of 159 mecA-positive isolates and 0 of 113 mecA-negative isolates were oxacillin resistant (positive and negative predictive values of 93 and 100%0/, respectively). Twenty-six isolates were categorized as indeterminate because of the absence of a detectable 16S rRNA product. Four of these 26 isolates contained mecA when retested. The assay is designed to be incorporated into the work flow of the clinical microbiology laboratory and allows for the identification of intrinsic resistance in a timely and reliable manner.
Methicillin-resistant staphylococci are significant pathogens that have emerged over the past 30 years to now cause both nosocomial and community acquired infections (8, 11, 34, 44) . Resistance is primarily mediated by the production of an altered penicillin-binding protein (PBP 2a) (7, 43) . This cell wall enzyme, unlike the other constitutive PBPs, has a low affinity for ,-lactam antibiotics and allows cell wall formation in concentrations of drug that render the other PBPs inactive. PBP 2a and the gene encoding it (mecA) have been found in all highly resistant staphylococci.
To date, the only standardized means of identifying methicillin resistance in the clinical microbiology laboratory are susceptibility tests, such as disk diffusion, agar or broth dilution, and agar screen methods (28, 29) . The performance of these tests has been erratic because many factors such as inoculum size, incubation time and temperature, pH of the medium, salt concentration of the medium, and exposure to 3-lactam antibiotics influence the phenotypic expression of resistance (13, 19, 35, 38, 46) . To complicate matters further, methicillin resistance is often expressed heterogeneously, in that only 104 to 107 cells are phenotypically resistant (12) . Taking into account these factors, the National Committee for Clinical Laboratory Standards (NCCLS) has set guidelines to maximize the phenotypic expression of resistance (28, 29) .
However, occasionally, organisms that are difficult to classify by these methods have been isolated. There is often discordance between results by disk diffusion and agar dilution. Although the NCCLS describes only one breakpoint for resistance (oxacillin MIC of >2 ,ug/ml), many investigators define a category of borderline or low-level resistance (1 to 8 ,ug/ml) that implies a mechanism other than that of PBP 2a (10, 23, 24, 35, 41) .
The empirical approach of most clinicians has been to view all levels of methicillin resistance as being equivalent to intrinsic, high-level resistance (23) . Intrinsic methicillin-resistant staphylococcal infections require vancomycin therapy (17, 27, 45) . In addition, intrinsic methicillin-resistant Staphylococcus aureus infections in many hospitals require strict patient isolation procedures. Staphylococcal strains with borderline resistance, lacking PBP 2a or the mecA gene, have been effectively treated with P-lactam antibiotics (5) . Furthermore, non-PBP 2a-bearing strains of S. aureus may not require expensive and inconvenient patient isolation procedures. Because intrinsic resistance of both S. aureus and coagulasenegative staphylococci (CNS) appears almost exclusively to be due to PBP 2a production, techniques have been developed to identify the mecA genetic determinant that codes for this protein. These assays utilize probe (2, 18) and PCR techniques (25, 31, 40) . These techniques show a high degree of correlation among susceptibility tests and allow accurate classification of not only highly resistant but also borderline-resistant strains (10) .
In this study, the largest of its kind to date, a multiplex PCR assay that uses primer sets specific for the mecA gene and a 16S rRNA universal target sequence was developed. The 16S rRNA gene, common to all bacteria (32) , was used as an internal control to identify potential false-negative results.
Isopsoralen compound 10 (HRI Associates, Concord, Calif.) was incorporated into the protocol to prevent false-positive PCR results. The test was designed to fit into the flow of daily susceptibility testing performed in the clinical microbiology laboratory. PCR results were compared with those of standard susceptibility methods (disk diffusion and agar dilution) (28, 29) . (29, 39) . A total of 104 CFU was spot inoculated onto Mueller-Hinton agar with 4% NaCl supplementation containing 6 jig of oxacillin per ml. Plates were read at 24 h of incubation at 30°C. Agar screen tests were done on all discrepant isolates (mecA positive, Oxs; mecA negative, Oxr). If any colonies of growth were detected, the test was considered positive for resistance.
MATERIALS AND METHODS
Amoxicillin-clavulanic acid disk tests. The amoxicillin-clavulanic acid (Augmentin) disk test was performed on the mecA-negative Oxr isolates. A 6.35-mm-diameter disk containing 20 jig of amoxicillin and 10 jig of clavulanic acid was placed on Mueller-Hinton agar without NaCl supplementation (29) . The breakpoint for susceptibility was a >-20-mm-diameter zone of inhibition after 24 h of incubation at 30°C.
Preparation of bacterial lysates. A 0.25-ml aliquot of the organism suspended in indole broth was centrifuged at 12,000 x g for 5 min. The supernatant was discarded, and the pellet was resuspended in 100 plI of cell lysis solution {250 U of lysozyme (Sigma Chemical Co., St. Louis, Mo.) per (30) . This increase in molecular weight, however, was reproducible from run to run and did not interfere with the interpretation of the results (Fig. 1) a For all organisms tested, the oxacillin MIC was 1. Agar dilution and disk diffusion tests were performed twice (test 1 and test 2) . By the agar screen test, which utilized 6 jig of oxacillin per ml in 4% NaCI-supplemented MuellerHinton agar, all organisms tested as susceptible.
initially oxr and 113 of 113 mecA-negative isolates were Oxs. Fourteen of 25 (56%) isolates which were classified initially as Oxs mecA positive expressed phenotypic resistance (MIC of >2 ,ug/ml) upon repeat susceptibility testing, leaving 148 of 159 oxr mecA-positive isolates. Thus, for CNS, the PPV and NPV were 93 (P = 0.0001) and 100%, respectively. The PPV of genotypic detection of oxr was relatively low because the discordant isolates could not be induced by agar screen testing to express phenotypic resistance. The Biolog (Hayward, Calif.) bacterial identification system was used to identify the discordant CNS isolates (mecA positive, Oxs) to the species level: seven S. epidermidis, three S. hominis, and one S. caprae isolates ( Table 2 ). None were inducible by agar screen testing, although several had intermediate (11-to 13-mm-diameter) zones by disk diffusion testing.
DISCUSSION
The identification of methicillin-resistant staphylococci in the laboratory is sometimes complicated by the heterogenous expression of resistance and the variables that influence this expression (i.e., pH, temperature, and salt concentrations). The NCCLS provides a breakpoint MIC for resistance, but many investigators advocate recognition of degrees of resistance that are clinically important. Borderline methicillin resistance varies from study to study to include MICs of oxacillin from-1 to 16 ,ug/ml with disk diffusion zone diameters of 6 to 13 mm (10, 23, 24, 35, 39, 41) . This category can involve non-PBP 2a-dependent mechanisms such as hyperproduction of 3-lactamase (23, 41) , the presence of other low-affinity PBPs (5, 41) , or production of a newly described methicillinase (22) . Chambers et al. (5) and Massanari et al. (21) have shown that differentiating high-level and borderline resistance is important in determining appropriate therapy. To date, the test sanctioned by the NCCLS is the salt-supplemented agar screen method to identify intrinsic resistance (29) . Although this method may lack sensitivity (10), the agar screen method was used in this study to evaluate discrepant organisms.
The rate of methicillin resistance in staphylococci (oxacillin MIC of >2) varies widely among institutions. S. aureus resistance rates range from 5% to over 50%, and CNS resistance ranges from 50 to 80% (1) . Because Isopsoralen was used in a post-PCR inactivation procedure (16, 30) . Psoralens intercalate into double-stranded nucleic acids, forming covalent interstrand cross-links after photoactivation with UV light. Depending on the length and G-C content of the amplification products, >99% of the amplicons are inactivated, thus decreasing the problem of amplicon carryover and the resulting false-positive reactions (16) . Incorporation of this step is important for an assay that is to be used daily in the clinical laboratory, especially when the rate of expected positive results is high. Genotypic detection of drug resistance will undoubtedly become an important component of the diagnostic armamentarium of the clinical laboratory. Guidelines for interpretation of the mecA gene result will need to be formally addressed as more laboratories begin to use this method. We propose that mecA-positive organisms (both CNS and S. aureus) be regarded as intrinsically resistant and that mecA-positive results, which can be available well before the phenotypic results (6 versus 24 h, respectively), be reported immediately. Although some of these isolates may be phenotypically borderline resistant or even susceptible when tested in vitro, all have the potential to become highly resistant, and infections with these organisms may well become refractory to 13-lactam antibiotic therapy (6, 26, 42) . Most mecA -negative organisms will remain phenotypically susceptible to oxacillin. Those organisms with borderline resistance (mecA negative, Oxr) may well respond to ,B-lactam antibiotics or 1-lactam-13-lactamase inhibitor combinations similar to Oxs organisms (5, 21) . PCR assays for determination of the mecA gene in staphylococci appear to be a beneficial adjunct to standard susceptibility testing and allow for the identification of intrinsic resistance in a timely and reliable manner. The cost to the laboratory depends on the volume of specimens tested. For this assay, the technologist time required to run an assay of up to 40 specimens was approximately 2 h. Since vancomycin continues to be the only drug that reliably eradicates intrinsically methicillin-resistant staphylococci, preservation of this drug for only intrinsic resistance may help to control high costs associated with its overuse and slow the potential development of vancomycin resistance.
